| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/19/2002 | US20020131992 Feeding dog a therapeutic agent comprising a vitamin D analog |
| 09/19/2002 | US20020131988 Provides flexibility in adjusting release of medicament; faster onset of release can be provided along with a long-term sustained-release |
| 09/19/2002 | US20020131983 Method for inducing an immunological response in a host by administering to the host at least one antigen and a lipoprotein |
| 09/19/2002 | US20020131967 Such as melphalan and an anti-interleukin-6 receptor antibody, administering in synergistic amounts |
| 09/19/2002 | US20020131966 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs |
| 09/19/2002 | US20020131965 Conjugate of a bioactive agent covalently attached to a transport polymer, having guanidino or amidino side chains, such as an arginine-containing polypeptide |
| 09/19/2002 | US20020131948 Tightening agent comprising at least one grafted silicone polymer |
| 09/19/2002 | US20020131940 Carotenoid preparation |
| 09/19/2002 | US20020131938 Prophylaxis and therapy of actinic keratosis comprising applying to the affected skin surface hydroximic acid derivative |
| 09/19/2002 | DE10113058A1 Verwendung von Lichtschutzmittelkombinationen, die als wesentlichen Bestandteil 2-(4-Alkoxy-anilinomethylen)-malonsäure-dialkylester enthalten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen Use of sunscreen combinations that as an essential constituent 2- (4-alkoxy-anilinomethylen) malonic acid dialkyl esters contain, as photostable UV filters in cosmetic and pharmaceutical preparations |
| 09/19/2002 | DE10112882A1 Selective cytostatic treatment of serotonin-producing tumors, using non-toxic tryptophan derivatives, e.g. 7-hydroxytryptophan, which are enzymatically converted into specific toxins in the tumor cells |
| 09/19/2002 | DE10112768A1 New heterocyclic-substituted phenyl compounds, are Factor Xa and Factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, restenosis or tumor diseases |
| 09/19/2002 | DE10112198A1 Substituierte Dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amine Substituted dimethyl- [1- (1-phenyl-cyclohexyl) -piperidin-3-ylmethyl] -amines |
| 09/19/2002 | DE10112151A1 New 5-(4-(indolyl-alkyl)-piperazino)-benzofuran-2-carboxamides useful e.g. for treating depression, anxiety, psychiatric or cerebral disorders or pain, are 5-HT-1A receptor agonists and 5-HT reuptake inhibitors |
| 09/19/2002 | DE10111843A1 Verbindungen zur Behandlung von inflammatorischen Erkrankungen Compounds for the treatment of inflammatory disorders |
| 09/19/2002 | DE10111842A1 Antithrombotische Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel Antithrombotic carboxamides, their preparation and their use as medicaments |
| 09/19/2002 | DE10110953A1 Transdermales therapeutisches System zur Verabreichung von partiellen Dopamin-D2-Agonisten Transdermal therapeutic system for administration of partial dopamine-D2 agonists |
| 09/19/2002 | DE10110754A1 Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 09/19/2002 | DE10110438A1 Substituierte 2-Oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 09/19/2002 | DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use |
| 09/19/2002 | CA2473156A1 Rxr activating molecules |
| 09/19/2002 | CA2470152A1 Transfection complexes comprising a novel peptide as cell surface receptor binding component |
| 09/19/2002 | CA2458479A1 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof |
| 09/19/2002 | CA2458451A1 Use of sugar phosphates, amino acids, amino acid analogs, e.g. carbomethoxypropionyl cyanide for reducing weight or diabetes complications |
| 09/19/2002 | CA2457234A1 Substituted tetracycline compounds as antifungal agents |
| 09/19/2002 | CA2452977A1 Facially amphiphilic polymers as anti-infective agents |
| 09/19/2002 | CA2448245A1 Topical composition comprising a functionally alkylating cosmetic bonding agent |
| 09/19/2002 | CA2441854A1 Composition for rectal delivery of an oxazolidinone antibacterial drug |
| 09/19/2002 | CA2441177A1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation |
| 09/19/2002 | CA2441174A1 Novel anti-adhesive compounds and uses thereof |
| 09/19/2002 | CA2441088A1 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof |
| 09/19/2002 | CA2441082A1 Steap-related protein |
| 09/19/2002 | CA2440973A1 Use of steroid derivatives for the treatment of a benighn and/or malignant tumour |
| 09/19/2002 | CA2440834A1 Anti-epileptogenic agents |
| 09/19/2002 | CA2440758A1 Substituted dimethyl-[1-(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-amines |
| 09/19/2002 | CA2440757A1 Substituted tetracycline compounds as synergistic antifungal agents |
| 09/19/2002 | CA2440670A1 Agent for therapeutic and/or prophylactic treatment of diabetic ischemic heart disease |
| 09/19/2002 | CA2440647A1 P-thienylbenzyl-amides serving as agonists of angiotensin-(1-7)-receptors, method for the production thereof, their use and pharmaceutical preparations containing the same |
| 09/19/2002 | CA2440641A1 Chronotherapeutic dosage forms containing glucocorticosteroid |
| 09/19/2002 | CA2440555A1 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 09/19/2002 | CA2440552A1 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
| 09/19/2002 | CA2440433A1 Cell culture system for synthesis of infectious hepatitis c virus |
| 09/19/2002 | CA2440412A1 Taste masked liquid pharmaceutical compositions |
| 09/19/2002 | CA2440374A1 A pharmaceutical composition for the treatment of depression comprising the ep1 antagonist as active ingredient |
| 09/19/2002 | CA2440319A1 Tumor radiosensitization and/or chemopotentiation using isocoumarin derivatives |
| 09/19/2002 | CA2440284A1 Ph-dependent nmda receptor antagonists |
| 09/19/2002 | CA2440225A1 Taxane prodrugs |
| 09/19/2002 | CA2440211A1 Benzimidazole anti-inflammatory compounds |
| 09/19/2002 | CA2440209A1 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same |
| 09/19/2002 | CA2440184A1 Heterocyclic derivatives for the treatment of cancer and other proliferative diseases |
| 09/19/2002 | CA2440167A1 Method to prepare microparticles that contain metoprolol |
| 09/19/2002 | CA2440163A1 Method to obtain microparticles containing a h+, k+ -atp-ase inhibitor |
| 09/19/2002 | CA2440158A1 Method to obtain microparticles containing a h+, k+-atp-ase inhibitor |
| 09/19/2002 | CA2439920A1 Antihypertensive agent and cholesterol absorption inhibitor combination therapy |
| 09/19/2002 | CA2439897A1 Enzyme-activated cytostatic conjugates with integrin ligands |
| 09/19/2002 | CA2439853A1 Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof |
| 09/19/2002 | CA2439612A1 Modulation of smooth muscle cell proliferation |
| 09/19/2002 | CA2439301A1 Compositions comprising matrine and dictamnine for treating or preventing cancer and other diseases |
| 09/19/2002 | CA2439231A1 Antithrombotic carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions |
| 09/19/2002 | CA2439063A1 Combination of nateglinide or repaglinide with at least one further antidiabetic compound |
| 09/19/2002 | CA2438874A1 Fluorinated trienes and their use as rxr modulators |
| 09/19/2002 | CA2438868A1 Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases |
| 09/19/2002 | CA2438586A1 Retinoid x receptor modulators |
| 09/19/2002 | CA2438401A1 Pharmaceutical composition |
| 09/19/2002 | CA2437932A1 Use of type 4 phosphodiesterase inhibitors in myocardial diseases |
| 09/19/2002 | CA2437746A1 Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein |
| 09/19/2002 | CA2436083A1 Use of dual h3/m2 antagonists in the treatment of cognition deficit disorders |
| 09/19/2002 | CA2434611A1 Combined method for treating hormono-dependent disorders |
| 09/19/2002 | CA2403380A1 Sustained release oral preparations |
| 09/18/2002 | WO2001070678A2 Substituted biphenyl derivatives |
| 09/18/2002 | WO2001070237A1 Use of organophosphorous compounds for producing a medicament for treating infections |
| 09/18/2002 | EP1241259A1 Peptide having pronociceptive properties |
| 09/18/2002 | EP1241254A1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same |
| 09/18/2002 | EP1241186A2 Human growth arrest specific gene 6 (gas-6) and nucleic acids encoding the same |
| 09/18/2002 | EP1241176A1 Purine derivatives for the treatment of ischemia |
| 09/18/2002 | EP1241170A2 Pyrazolopyrimidine derivatives |
| 09/18/2002 | EP1241169A1 Isoindoloindolone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 09/18/2002 | EP1241168A1 Human NK3 receptor-selective antagonist compounds, process for their obtention and pharmaceutical compositons containing them |
| 09/18/2002 | EP1241162A1 2,2'-bi-1H-pyrrole derivatives with immunosuppressant activity |
| 09/18/2002 | EP1241113A1 Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein |
| 09/18/2002 | EP1240922A2 Methods and compositions for overcoming resistance to biologic and chemotherapy |
| 09/18/2002 | EP1240906A1 Preventives or remedies for arrhythmia |
| 09/18/2002 | EP1240903A2 Combination of calcium (3S) tetrahydro-3-furanyl(1S,2R)-3- [[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphonooxy) propylcarbamate with ritonavir |
| 09/18/2002 | EP1240899A2 Modulation of Th1/Th2 Cytokine expression by Ribavirin and Ribavirin analogs in actived T-Lymphocytes for treating HCV infections |
| 09/18/2002 | EP1240898A2 Use of 2-deoxy ecdysterone for the preparation of a medicament for inducing labour or abortion |
| 09/18/2002 | EP1240897A1 Pharmaceutical tablet and process for making thereof |
| 09/18/2002 | EP1240894A2 Use of sunscreening combinations in cosmetic and pharmaceutical preparations |
| 09/18/2002 | EP1240521A2 Identification of disease markers involving mass-based-separation |
| 09/18/2002 | EP1240345A2 Methods for expression of genes in primates |
| 09/18/2002 | EP1240328A1 Antigenic protein lppq of mycoplasma mycoides subsp. mycoides sc., its preparation and use |
| 09/18/2002 | EP1240325A2 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| 09/18/2002 | EP1240324A2 Polypeptides and nucleic acids encoding same |
| 09/18/2002 | EP1240322A2 Therapeutic uses of lna-modified oligonucleotides |
| 09/18/2002 | EP1240313A2 Homologues of human heparanase and splice variants thereof |
| 09/18/2002 | EP1240285A1 Stabilisation of pigments and polyunsaturated oils and oil concentrates |
| 09/18/2002 | EP1240265A2 1,1-disubstituted ethylene adhesive compositions containing polydimethylsiloxane |
| 09/18/2002 | EP1240199A2 Method for screening of appetite control agents |
| 09/18/2002 | EP1240196A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 09/18/2002 | EP1240190A1 Uses of transport proteins for controlling cell cycle |
| 09/18/2002 | EP1240182A2 Daptomycin analogs and their use as antibacterial agents |